Medication Management is an educational series about programs that support plan members, while continuing to protect the plan sponsors’ bottom line.
Specialty medications can significantly improve plan members’ health, but may also have a large impact on private drug plan budgets. As more specialty medications become available for a wider variety of chronic conditions, the balance between appropriate access and appropriate coverage becomes more challenging. Through their patient support programs, pharmaceutical manufacturers seek to help maintain that balance by ensuring that patients meet Canadian clinical guidelines, by supporting adherence to medications and by helping patients navigate reimbursement options.
This installment of Medication Management seeks to prompt additional discussion about the evolution of drug plan design to better accommodate specialty medications, and the roles of benefits advisors and insurance carriers to help plan sponsors define and evaluate the objectives of their drug benefit plan.
